Assessment of Gastrointestinal Clinical and Laboratory Features and Their Prognostic Implications in Hospitalized COVID-19 Patients: A Prospective Cohort Analysis - Takeaways - MDSpire

Assessment of Gastrointestinal Clinical and Laboratory Features and Their Prognostic Implications in Hospitalized COVID-19 Patients: A Prospective Cohort Analysis

  • By

  • Thiago Henrique Fernandes de Carvalho

  • Fabyan Beltrão Esberard

  • Maryana Cavalcanti Holanda

  • Matheus Venâncio de Paiva

  • Daniele Carvalhal de Almeida Beltrão

  • Giulia Carvalhal

  • José Felipe Lacerda Fernandes

  • Carlos Alexandre Antunes de Brito

  • February 13, 2026

  • 0 min

Share

  • 1

    The study assessed gastrointestinal symptoms and liver enzyme alterations in 253 hospitalized COVID-19 patients in northeastern Brazil.

  • 2

    Gastrointestinal symptoms were previously reported at varying incidences, with this study aiming to clarify their association with disease severity.

  • 3

    Patients were classified into severe and critical categories based on respiratory and organ failure criteria for better prognostic evaluation.

  • 4

    Blood samples were collected within 48 hours of admission to measure liver enzymes and other relevant biomarkers for analysis.

  • 5

    The study's findings aim to enhance understanding of COVID-19's clinical features and inform prognostic models in localized settings.

Original Source(s)

Assessment of Gastrointestinal Clinical and Laboratory Features and Their Prognostic Implications in Hospitalized COVID-19 Patients: A Prospective Cohort Analysis

  • by Thiago Henrique Fernandes de Carvalho, Fabyan Beltrão Esberard, Maryana Cavalcanti Holanda, Matheus Venâncio de Paiva, Daniele Carvalhal de Almeida Beltrão, Giulia Carvalhal, José Felipe Lacerda Fernandes, Carlos Alexandre Antunes de Brito

  • February 13, 2026

Related Content

Recent COVID-19 Shot Linked to Less Spread

Protection against spread appeared strongest within 6 months of vaccination, while exposed vaccinated contacts showed no measurable reduction in infection risk.

Editorial: Lipid influence on lung immune-structural cell crosstalk: implications for respiratory health

Epidemiology of respiratory syncytial virus in a German hospital before, during and after the COVID-19 pandemic – a real world monocentric analysis over ten years